1 Min Read
March 31 (Reuters) - Repros Therapeutics Inc:
* Repros Therapeutics Inc reports fourth quarter and year end 2016 financial results
* Q4 loss per share $0.16 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.